GlassScriptPhysician profile
Mohammad A Sharif
NPI 1851357164
$79,007.95
in general payments reported to CMS, 2019-2025
50 companies · $12K in 2025
The $12K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $3,114 · 2021: $13K · 2022: $12K · 2023: $8,713 · 2024: $13K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Travel and Lodging: $4,171 · Food and Beverage: $4,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,431.25 |
| Travel and Lodging | $4,171.32 |
| Food and Beverage | $4,053.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $51,823.77 | 2020-2025 | Truelok, Trinity Elite, Sambascrew |
| Wright Medical Technology, INC. | $14,628.72 | 2019-2020 | |
| Smith+Nephew, INC. | $5,110.29 | 2019-2025 | Grafix, Grafix Pl, Grafix Xc |
| Stryker Corporation | $1,782.71 | 2020-2025 | T2 Alpha, Salvation, Hoffmann |
| United Orthopedics LLC | $962.43 | 2020 | |
| Integra Lifesciences Corporation | $937.32 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $655.79 | 2022-2025 | Cerament G, Ceramentbone Void Filler |
| In2bones USA, LLC | $335.19 | 2019 | |
| Organogenesis INC. | $247.02 | 2019-2023 | Puraply |
| Axogen | $206.35 | 2020-2025 | |
| Medline Industries LP | $203.79 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $165.01 | 2021-2025 | Nuzyra |
| Grt US Holding, INC. | $163.35 | 2020-2022 | |
| Melinta Therapeutics, LLC | $137.62 | 2019-2023 | Orbactiv, Kimyrsa |
| Depuy Synthes Sales INC. | $135.84 | 2020-2021 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $124.57 | 2024 | Celleraterx |
| Osiris Therapeutics INC. | $113.13 | 2019 | |
| Progenacare Global, LLC | $95.10 | 2023 | |
| Kerecis Limited | $94.58 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Horizon Therapeutics Plc | $82.18 | 2019 | |
| Zimmer Biomet Holdings, INC. | $78.54 | 2019-2020 | |
| Treace Medical Concepts, INC. | $69.92 | 2023-2025 | |
| Globus Medical, INC. | $56.95 | 2025 | Senza |
| Biocomposites INC | $52.47 | 2021 | |
| Polynovo North America LLC | $50.82 | 2022-2024 | Novosorb Btm |
| Averitas Pharma INC. | $50.03 | 2023 | Qutenza |
| Abbvie INC. | $48.77 | 2023 | Teflaro, Dalvance |
| Bioventus LLC | $44.06 | 2022-2023 | Stimrouter Implantable Kit, Theragenesis Bilayer Wound Matrix |
| Convatec INC. | $39.44 | 2021-2023 | |
| Aroa Biosurgery Incorporated | $39.23 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $38.41 | 2019 | |
| Zimvie INC. | $35.74 | 2022-2023 | |
| Spine Wave, INC. | $34.33 | 2021 | |
| Surgenex LLC | $30.68 | 2025 | Renograft, Surmatrix, Ardeograft |
| Osteomed LLC | $28.58 | 2019 | |
| Nevro Corp. | $28.13 | 2022 | |
| Avita Medical Americas, LLC | $26.39 | 2025 | Recell, Permeaderm, Cohealyx |
| Acera Surgical, INC. | $23.94 | 2019 | |
| Paragon 28, INC. | $23.71 | 2020-2023 | Baby Gorilla |
| Polarityte, INC. | $22.95 | 2019 | |
| Abbott Laboratories | $22.66 | 2021 | |
| Kci USA, INC. | $22.46 | 2023 | V.A.C. Veraflo |
| Solventum Corporation | $21.77 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Nabriva Therapeutics, Plc | $20.47 | 2022 | |
| Triad Life Sciences INC. | $20.26 | 2022 | |
| Sebela Pharmaceuticals INC. | $17.82 | 2020 | |
| Glenmark Therapeutics INC. | $15.00 | 2019 | |
| Hydrofera LLC | $13.65 | 2023 | Hydrofera Blue |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2022 | |
| Ethicon US, LLC | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Sharif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.